AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the latest on coronavirus treatments, including Merk’s COVID pill, as well as research outlining the positive effects of getting vaccinated during pregnancy.
Read MoreIn part three of this three-part series, Aimee Hodowanec, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what physicians need to know about Molnupiravir as treatment for COVID-19.
Read MoreAMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the FDA’s pivot to wait for more data on vaccines for kids under 5, and what new data from the CDC tells us about booster shots.
Read MoreIn part two of this three-part series, Stephanie Troy, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what to know about Paxlovid as treatment for COVID-19.
Read MoreAMA CXO Todd Unger dives into new developments from ACIP’s emergency meeting on Feb. 4 with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.
Read MoreAMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering new data coming from the CDC solidifying wearing high-quality N95 and KN95 masks provide the best chance of avoiding infection, as well as the addition of a new data point to the CDC’s COVID data tracker.
Read MoreAMA CXO Todd Unger is joined by the AMA’s president, Gerald Harmon, MD, a family medicine specialist in Pawleys Island, S.C., who shares new information and big takeaways about therapeutics for COVID-19 after his recent conversation with three physician leaders from the FDA.
Read MoreAMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia, JD, MPH. Also covering the World Health Organization’s (WHO) opinion on life post-Omicron, as well as newly published data from the CDC, JAMA, and what that research means in the battle against the current U.S. COVID surge. Additionally, the FDA has revised authorizations for two monoclonal antibody treatments—a topic AMA’s immediate past-president, Susan Bailey, MD, will be discussing in an upcoming webinar with experts from the FDA.
Read MoreAMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering developments in COVID hot spots across the nation, the CDC’s clarified stance on masks, and Dr. Fauci’s «five phases of the pandemic.»
Read MoreAMA CXO Todd Unger talks with Leonard Nelson, JD, the AMA’s senior assistant general counsel, about the recent Supreme Court decisions on vaccine mandates and their long-term implications for physicians.
Read More